CVE Intelligence
Skip to main content

CVE-2018-14786

CVE-2018-14786 Vulnerability Analysis & Exploit Intelligence

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Published Updated Sources: cvelistV5, icscert

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Unreported

no source claims exploitation

EPSS

3%

chance of exploitation in 30 days

Affects

becton dickinson and

alaris_gs_alaris_gh_alaris_cc_and_alaris_tiva

CVSS base

Unscored

no source published a base score

Affected scope

The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.

Products (1)

alaris gs alaris gh alaris cc and alaris tiva

Weakness & attack patterns

  • CWE-287

Attack patterns reported against this CVE. The ATT&CK techniques below are inferred from its weakness class.

  • T1548Abuse Elevation Control Mechanism
  • T1040Network Sniffing
  • T1185Browser Session Hijacking

References

3 on the record

Elsewhere on this site

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.